Most patients with bowel cancer not advised to exercise despite its health benefits
the ONA take:
Many patients with bowel cancer say they were not advised to exercise regularly after diagnosis. Exercise can help ease fatigue, depression, and anxiety; is linked to better survival and better quality of life for patients; and reduces the risk of recurrence.
However, a Cancer Research UK study has shown that many patients are not advised to be more active.
The researchers asked more than 15,000 patients with bowel cancer about their current level of exercise and whether they were advised to be more active.
Only 31% said they were advised to exercise at any point during their treatment, 69% said they were not advised at all.
Current NHS guidelines recommend that healthy people get at least 2.5 hours of moderate physical activity per week.
Although no guidelines specific to patients with bowel cancer are in place, the researchers recommend that patients discuss exercise with their doctor and get advice on what is safe for them and suits their lifestyle and ability.
Many patients with bowel cancer say they were not advised to exercise regularly after diagnosis.
Sign Up for Free e-newsletters
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
- Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer
- Prognostic Factors for Survival Among Patients With Primary Bone Sarcomas of Small Bones
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- A Call for More Tailored Cancer Education Programs to Improve Screening
- Aligning Patient Goals With End of Life Treatment Decisions
- Study Suggests Greater Focus on the Needs of Family Caregivers of Patients With Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|